– , /PRNewswire/ -- Visby MedicalTM and the Johns Hopkins Medicine Department of Emergency Medicine announced findings from a study evaluating a new approach to management of the three most common non-viral sexually transmitted infections (STI) in women. The study found that use of the Visby Medical Sexual Health Test, a point-of-care (POC) polymerase chain reaction (PCR) test, shortened time from specimen collection to STI result to only 47 minutes per patient, compared to an average of 25 hours for the standard of care (SOC) lab-processed molecular send-out tests. The Visby Medical test also resulted in significantly higher rates of appropriate treatment and lower rates of over-treatment with antibiotics for (CT) and (NG) infections, compared to SOC .
Full data were presented on at the 2024 annual meeting of the Society for Academic Emergency Medicine (SAEM). The Visby Medical Sexual Health Test is the only "instrument-free" POC test available in the U.S.
that provides PCR results in under 30 minutes. In , the Visby Medical test received 510(k) clearance and was granted a CLIA waiver from the U.S.
Food and Drug Administration for its second-generation POC test. An STI surveillance report published in 2024 by the U.S.
Centers for Disease Control (CDC) found more than 2.5 million cases in 2022 . At the same time, the rate of inappropriate use of antibiotics to treat STIs has contributed to antimicrobial resistant strains of NG, prompting the World Health Organization (WHO) .
